Pages that link to "Q36046528"
Jump to navigation
Jump to search
The following pages link to Temozolomide in the treatment of solid tumours: current results and rationale for dosing/scheduling (Q36046528):
Displaying 24 items.
- Genotoxic anti-cancer agents and their relationship to DNA damage, mitosis, and checkpoint adaptation in proliferating cancer cells (Q26851196) (← links)
- Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life (Q33270398) (← links)
- A Phase I trial of protracted oral fixed-dose temozolomide (Q33368231) (← links)
- Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis (Q33430404) (← links)
- Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention (Q33772624) (← links)
- A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response (Q35602183) (← links)
- Metronomic treatment of temozolomide increases anti-angiogenicity accompanied by down-regulated O(6)-methylguanine-DNA methyltransferase expression in endothelial cells (Q36230477) (← links)
- NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug (Q36552658) (← links)
- A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer (Q36667516) (← links)
- Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates (Q36668246) (← links)
- Efficacy of protracted temozolomide dosing is limited in MGMT unmethylated GBM xenograft models (Q36866006) (← links)
- New developments in the treatment of malignant gliomas (Q36972696) (← links)
- Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model (Q37284263) (← links)
- Preparation of Temozolomide-Loaded Nanoparticles for Glioblastoma Multiforme Targeting-Ideal Versus Reality (Q37290850) (← links)
- Amino acid Asp181 of 5'-flap endonuclease 1 is a useful target for chemotherapeutic development (Q37474607) (← links)
- Insights into pharmacotherapy of malignant glioma in adults (Q37575528) (← links)
- Combination hyperbaric oxygen and temozolomide therapy in c6 rat glioma model (Q39336771) (← links)
- Cell cycle effects and increased adduct formation by temozolomide enhance the effect of cytotoxic and targeted agents in lung cancer cell lines (Q39830999) (← links)
- Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models. (Q39897760) (← links)
- O-methylguanine-DNA methyltransferase immunoexpression in a double pituitary adenoma: case report. (Q39908548) (← links)
- Minimally cytotoxic doses of temozolomide produce radiosensitization in human glioblastoma cells regardless of MGMT expression (Q40538138) (← links)
- Use of temozolomide in aggressive pituitary tumors: case report (Q46086307) (← links)
- Disposition of temozolomide in a patient with glioblastoma multiforme after gastric bypass surgery (Q46174216) (← links)
- A phase II study of thalidomide in patients with brain metastases from malignant melanoma. (Q46496647) (← links)